Endocannabinoids modulate human blood-brain barrier permeability in vitro
about
Dietary Capsaicin Protects Cardiometabolic Organs from DysfunctionHIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsThe Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and DifferentiationCannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activationN-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP/PKA-dependent signaling.The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries.Endocannabinoids: A Promising Impact for Traumatic Brain Injury.Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors.In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities.Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic PainAn update on PPAR activation by cannabinoids.The Noncompetitive AMPAR Antagonist Perampanel Abrogates Brain Endothelial Cell Permeability in Response to Ischemia: Involvement of Claudin-5.Sirt1-Sirt3 axis regulates human blood-brain barrier permeability in response to ischemia.Capsaicin protects cortical neurons against ischemia/reperfusion injury via down-regulating NMDA receptors.Predictors of early-onset post-ischemic stroke depression: a cross-sectional study.Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors.
P2860
Q26749367-EB49FBBF-155C-4A0E-8ACD-C4BB43A86CF1Q28392199-2EA2B86C-54CB-4E63-8549-36AC5CA14996Q35790543-A7B40574-E7BC-49D6-9E53-5AB5B8461A1AQ35966006-D3CC1492-54AB-4357-944E-0735E9221347Q37394743-541759F0-81BD-4453-A51B-326A91C42A76Q37420729-DC8DEDED-F126-4CE1-8D2C-5F9E33C9F882Q37648343-41B1D40D-0EEF-46CC-831F-A098AF4320FFQ38563981-2F07DEC6-02C2-4505-8D38-86F70F6C49A8Q38572902-554EB2BC-0234-4D8D-9046-1CC4BB1FE18BQ38753758-767BCCE7-2A5B-4C33-AE02-C49FF965B24AQ38754299-5DE53A6B-3868-4A68-9EB4-6C9D7E052C88Q38808034-5D24E713-A48E-4CEC-B8BB-43DC947978E8Q40607738-F6B95D61-9F3F-441B-87CF-452FF4D61FA4Q42095065-922DB2BF-1486-4525-A082-5AFFE75FCD5EQ46756114-1FD9EF04-E25A-47FB-A7FE-7462FE29809AQ47133238-3DCB93AF-ED11-4D0D-B32E-70ECDAA425E1Q47739408-1960250B-264E-4A6E-A984-A83AEF5E9B67Q47744626-30BA9094-162E-4185-AC41-B7750F9261B6
P2860
Endocannabinoids modulate human blood-brain barrier permeability in vitro
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Endocannabinoids modulate human blood-brain barrier permeability in vitro
@en
Endocannabinoids modulate human blood-brain barrier permeability in vitro
@nl
type
label
Endocannabinoids modulate human blood-brain barrier permeability in vitro
@en
Endocannabinoids modulate human blood-brain barrier permeability in vitro
@nl
prefLabel
Endocannabinoids modulate human blood-brain barrier permeability in vitro
@en
Endocannabinoids modulate human blood-brain barrier permeability in vitro
@nl
P2093
P2860
P50
P356
P1476
Endocannabinoids modulate human blood-brain barrier permeability in vitro
@en
P2093
Maria Neophytou
Susan I Anderson
William H Hind
P2860
P304
P356
10.1111/BPH.13106
P407
P577
2015-04-10T00:00:00Z